InvestorsHub Logo
Followers 21
Posts 4211
Boards Moderated 0
Alias Born 05/10/2012

Re: None

Tuesday, 12/29/2020 2:34:11 PM

Tuesday, December 29, 2020 2:34:11 PM

Post# of 144813
Bottom line...pmcb has filed an IND with the fda for a phase 2b clinical trial for an unmet need in pancreatic cancer...the technology allows the cancer patient to receive only 1/3 the normal chemotherapy to treat the cancer as the cells are placed at the site of the tumor...so no toxicity to the body...tumor shrinkage occurs within 3 to 6 months for removal...this technology will become extremely valuable should the fda approve the IND...there will be many big pharmas watching this...no doubt buyout offers will come.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News